Alzheimer's Disease (Video)

Eric Siemers, MD, Distinguished Medical Fellow at Eli Lilly and Company joins William Mobley, MD, PhD to discuss clinical trails for Alzheimer's disease. He explains the trial design, results, and future implications of the EXPEDITION3 trial for people with with mild dementia due to Alzheimer's disease. Learn more about potential treatments in the clinical trials pipeline that may impact both the symptoms and pathologies of Alzheimer's disease. Series: "Alzheimer’s Disease" [Health and Medicine] [Show ID: 31802]

Phyllis Ferrell, Vice President and Global Development Leader for

Alzheimer's Disease at Eli Lilly and Company joins William Mobley, MD, PhD to talk about the goal set forth in the National Plan to Address Alzheimer’s Disease to “prevent and effectively treat Alzheimer’s disease by 2025.” Ferrell's shares her work to make Alzheimer's dementia preventable by finding ways to slow disease progression and advocating for early diagnosis. Series: "Alzheimer’s Disease" [Health and Medicine] [Show ID: 31803]

From neuropathology to molecular target to clinical treatments, where are we on the road to finding an effective treatment for Alzheimer's disease? Howard Feldman, MD, FRCP(C), a neurologist noted for his original research in geriatric cognitive disorders and expertise in large-scale clinical trials, walks through the latest research and shares some tips on brain health. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 31035]

For the past three decades the largest family in the world with a genetic form of Alzheimer’s disease has been tracked. This extended family of some 5,000 individuals live in Antioquia, Colombia among a people who call themselves Paisa. Passing relentlessly through the generations with 100% penetrance is a mutation that causes early onset Alzheimer’s disease in its carriers. Dr. Kenneth Kosik explains that the mutation in the Americas likely originated from a Spanish conquistador whose progeny are the members of the family we see today. Recently, interest in the family has grown because they are now participating in a clinical trial intended to delay the onset of the disease. Series: "The Brain Channel" [Health and Medicine] [Science] [Show ID: 31481]

Dr. Elissaios Karageorgio explains the link between broken sleep patterns that are characteristic of insomnia and dementia. Series: "The UC Wellbeing Channel " [Health and Medicine] [Show ID: 31201]

What is the relationship between sleep, brain health, and Alzheimer's disease? Series: "The UC Wellbeing Channel " [Health and Medicine] [Show ID: 31286]

Dr. Gary Small talks about how to reprogram brain chemistry through repetition, and highlights which foods the brain-conscious dieter eat. Series: "The UC Wellbeing Channel " [Health and Medicine] [Show ID: 31229]

Dr. Gary Small examines the correlation between inflammation and memory loss, and explains why exercise may have the power to stave off the effects of Alzheimer’s disease. Series: "The UC Wellbeing Channel " [Health and Medicine] [Show ID: 31228]

A panel of experts discusses the PBS NOVA program Can Alzheimer's Be Stopped? and the disease itself. Join Kenneth Kosik, MD (Co-Director Neuroscience Research Institute UC Santa Barbara), Sarah Holt (Producer and Director HHMI/Tangled Bank Studios), and Rhonda Spiegel (CEO, Alzheimer’s Association, California Central Chapter) and Francisco Lopera, MD (Professor of Behavioral Neurology, Chief of Neurosciences Program-University of Antioquia, Coordinator Group of Neurosciences of Antioquia). The discussion is moderated by Julia Cort, Deputy Executive Producer for NOVA. Series: "Carsey-Wolf Center" [Health and Medicine] [Show ID: 31017]

With our aging population the incidence of brain disorders such as Alzheimer’s disease are predicted to reach epidemic proportions. Look at AD and other neurodegenerative disorders. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [Health and Medicine] [Show ID: 30142]